Drugs / human Mesenchymal Stem Cell (MSC)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04174898 | Apr 2020 → Apr 2021 | — | Landmark Medical Centre Sdn Bhd | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human Mesenchymal Stem Cell (MSC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04174898 ↗ |
| Modality | Cell therapy | “human Mesenchymal Stem Cell (MSC) infusion therapy” NCT04174898 ↗ |
| Route | Intravenous | “intravenously” NCT04174898 ↗ |